≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other/unspecified crystal arthropathies

DOID Endpoint Browser PheWeb

CHRYSTAL_NOS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M11.8, M11.9
  • Hospital discharge: ICD-9 — 712[8-9]
  • Cause of death: ICD-10 — M11.8, M11.9
  • Cause of death: ICD-9 — 712[8-9]

2 out of 7 registries used, show all original rules.

203

4. Check minimum number of events

None

203

5. Include endpoints

None

203

6. Filter based on genotype QC (FinnGen only)

203

Control definitions (FinnGen only)

Control exclude
RHEUMA_CHRYSTAL

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1547 864 670
Only index persons 1294 716 578
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.02
Only index persons 0.02 0.03 0.02
Median age at first event (years)
Whole population 73.60 75.80 70.78
Only index persons 72.74 74.85 70.12

-FinnGen-

Key figures

All Female Male
Number of individuals 203 104 99
Unadjusted period prevalence (%) 0.04 0.04 0.04
Median age at first event (years) 69.74 68.37 71.17

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
178
Matched controls
1778
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M11.9
ICD-10 Finland
Crystal arthropathy, unspecified
+∞
106.2
91
*
M11.8
ICD-10 Finland
Other specified crystal arthropathies
+∞
95.7
83
*
M13.9
ICD-10 Finland
Arthritis, unspecified
11.2
29.1
59
75
M11.2
ICD-10 Finland
Other chondrocalcinosis
112.0
19.0
20
*
N02AX02
ATC
tramadol; systemic, rectal
4.3
18.8
117
550
M10.9
ICD-10 Finland
Gout, unspecified
7.4
15.7
39
65
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
5.2
14.5
49
121
M17.1
ICD-10 Finland
Other primary gonarthrosis
3.7
13.6
74
286
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
6.7
13.3
35
63
H02AB06
ATC
prednisolone; systemic
3.3
13.0
116
642
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
18.0
11.9
18
11
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
3.7
10.3
49
164
M79.6
ICD-10 Finland
Pain in limb
2.8
9.7
85
434
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
9.3
105
619
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
9.2
40
124
L15
ICPC
Knee symptom/complaint
3.1
8.4
55
227
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
3.8
8.3
37
116
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
7.7
7.7
17
24
N02AJ06
ATC
codeine and paracetamol; systemic
2.5
7.7
80
437
J01FF01
ATC
clindamycin; systemic
2.6
7.3
65
322
UKC02
NOMESCO Finland
Cystoscopy
2.9
7.2
47
195
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
3.6
7.1
33
107
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.3
7.0
38
137
X59
ICD-10 Finland
Exposure to unspecified factor
2.8
6.9
50
218
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.4
6.7
32
107
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
15.0
6.5
10
7
N03AX16
ATC
pregabalin; oral
2.5
6.3
56
273
J01DB01
ATC
cefalexin; oral
2.7
6.3
149
1174
A46
ICD-10 Finland
Erysipelas
2.9
6.2
41
167
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.8
6.1
25
73
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
5.1
6.1
18
38
SPAT1211
SPAT
Application of soft bandage
3.6
6.1
27
85
B01AA03
ATC
warfarin; systemic
2.4
6.1
59
304
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.8
6.0
40
165
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.6
6.0
26
80

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
85
45
31.77
114.83
1.8
1.2
—
—
—
0
0
52
25
27.62
71.34
2.3
1.5
—
—
—
0
0
60
40
20.87
71.25
2.2
1.4
32995.6
35029.0
e6/l
0.03
42
25
38
26
17.75
43.67
1.9
1.4
—
—
—
0
0
97
269
5.99
35.53
2.6
1.9
—
—
—
0
0
25
14
20.22
31.28
1.2
1.0
72906.3
617861.1
e6/l
—
16
9
123
463
5.20
30.30
3.7
2.6
337.3
5601.8
umol/l
1.77
110
387
79
234
4.89
25.58
1.5
1.3
4.9
11.0
u/ml
0.59
31
91
75
252
4.13
19.94
1.5
1.3
18.6
33.0
iu/ml
1.31
20
87
50
134
4.62
17.76
4.7
3.5
100.5
85.8
ng/l
0.37
39
116
109
524
3.33
16.07
8.1
5.1
—
—
—
0
0
59
194
3.88
15.78
1.6
1.4
512.7
601.6
titre
0.20
11
50
69
255
3.58
15.48
3.2
2.4
20.3
22.2
%
0.63
61
214
104
500
3.21
15.09
7.9
4.2
—
—
—
0
0
45
128
4.23
14.63
2.7
2.3
—
—
—
0
0
139
801
3.33
14.59
8.7
5.4
1.8
2.0
e9/l
0.45
120
707
137
786
3.29
14.42
8.8
5.3
0.7
0.6
e9/l
1.52
117
679
137
790
3.26
14.22
8.8
5.3
0.0
0.0
e9/l
0.49
117
685
72
293
3.26
13.62
3.3
2.3
10.6
12.7
umol/l
2.24
66
262
50
163
3.74
13.37
3.5
2.5
69.6
67.7
e9/l
0.13
36
135
132
763
3.09
13.30
9.0
5.4
24.8
26.8
%
1.05
125
700
127
719
3.05
13.28
9.0
5.3
0.7
0.6
%
0.27
121
664
130
749
3.05
13.10
9.0
5.3
2.9
2.7
%
0.32
124
692
130
754
3.01
12.85
9.2
5.6
9.7
8.7
%
1.58
124
703
137
818
3.08
12.84
9.0
5.5
0.2
0.2
e9/l
0.41
118
717
144
900
3.06
12.12
11.2
5.8
1.2
1.2
mmol/l
0.17
120
758
128
753
2.89
12.03
8.6
5.2
59.8
58.1
%
0.64
121
697
91
455
2.81
11.59
2.9
2.1
3.7
3.3
mg/l
0.39
75
393
57
222
3.18
11.38
3.1
2.6
1.9
1.8
%
0.26
48
197
44
147
3.54
11.22
3.0
3.1
67.2
66.6
g/l
0.21
38
132
134
827
2.82
11.16
9.9
5.1
1.2
1.2
mmol/l
0.18
123
746
165
1200
3.00
8.98
7.9
4.3
21.7
13.7
mm/h
5.28
156
1098
121
760
2.47
8.94
16.1
10.7
1.4
1.4
inr
0.36
40
219
110
666
2.42
8.76
3.8
2.6
146.1
129.3
ug/l
0.54
98
595
141
955
2.56
8.75
11.4
8.5
4.7
4.2
e9/l
1.19
123
836
118
741
2.41
8.61
6.7
4.1
39.4
48.5
ng/l
0.35
101
550
18
37
5.24
8.54
3.7
4.1
—
—
—
0
0
157
1141
2.66
8.04
8.1
4.6
—
—
—
0
0
93
540
2.33
7.95
2.9
2.1
175.8
223.1
u/l
0.30
88
505
17
38
4.79
7.33
1.3
1.7
—
—
—
0
0
133
923
2.28
7.13
7.3
6.0
10.6
11.2
umol/l
0.28
127
868
81
465
2.23
6.90
1.8
1.6
20.8
21.2
nmol/l
0.08
65
385
96
593
2.17
6.79
4.1
3.4
2.4
2.4
mmol/l
0.03
83
507
121
824
2.16
6.59
7.2
4.2
0.0
0.0
estimate
0.00
33
171
25
81
3.38
6.57
1.8
1.9
1.6
1.6
g/l
0.03
20
70
71
401
2.19
6.18
3.8
2.7
6.5
4.3
e6/l
0.45
64
355
165
1300
2.44
5.92
12.4
7.4
82.6
79.9
u/l
0.27
158
1207
35
150
2.61
5.63
13.5
6.6
11.1
9.9
mmol/l
0.46
35
141
118
826
2.02
5.63
9.0
5.6
0.0
0.0
estimate
0.00
33
164
110
753
2.01
5.57
2.3
2.0
104.8
93.3
pmol/l
1.18
55
373
87
549
2.02
5.54
7.0
4.0
7.4
7.4
ph
1.64
23
109
106
719
1.99
5.48
16.8
10.6
0.0
0.0
e9/l
0.59
87
601
40
186
2.43
5.43
2.7
1.6
—
—
—
0
0
67
387
2.09
5.40
2.2
1.7
1463.4
1218.5
nmol/l
0.91
48
292
23
80
3.11
5.40
1.1
1.3
—
46.1
—
0
7
84
531
1.99
5.26
5.3
4.2
—
—
—
0
0
18
55
3.49
5.16
3.9
2.2
1.6
1.7
mg/l
0.33
18
48
97
649
1.95
5.12
6.0
3.9
43.6
97.0
e6/l
1.17
76
483
22
77
3.08
5.11
1.4
1.2
—
—
—
0
0
117
837
1.94
5.03
7.4
4.2
0.0
0.0
estimate
0.00
32
161
78
491
1.96
4.87
5.0
3.1
—
—
—
0
0
37
175
2.36
4.82
8.0
3.1
—
—
—
0
0
83
538
1.92
4.73
3.2
2.4
—
—
—
0
0
64
380
2.00
4.70
4.2
3.0
525.9
547.5
mosm/kgh2o
0.41
56
332
88
584
1.89
4.65
5.2
3.3
—
—
—
0
0
80
521
1.88
4.43
5.1
3.2
0.4
0.4
e6/l
0.21
67
403
86
577
1.85
4.32
5.2
3.3
50.6
168.3
e6/l
0.54
70
461
7
6
12.02
4.30
1.3
1.3
273.0
140.8
iu/ml
—
7
6
72
457
1.89
4.30
9.0
4.5
0.0
0.0
estimate
0.00
33
162
77
503
1.86
4.18
3.5
3.1
7.2
7.3
mmol/l
0.07
60
407
48
267
2.04
4.18
2.5
1.9
30.4
30.0
s
0.09
48
259
77
504
1.85
4.15
3.4
3.1
998.0
58.1
mg/l
0.52
48
333
34
166
2.26
4.10
2.0
1.6
—
—
—
0
0
7
7
10.30
4.04
1.3
1.3
—
—
—
0
0
30
140
2.34
4.01
11.4
6.3
—
—
—
0
0
59
359
1.91
3.96
1.8
1.7
1.3
1.3
mg/l
0.04
50
280
17
60
3.00
3.90
4.9
3.6
0.3
0.1
g/l
—
8
19
12
34
3.69
3.83
3.3
2.6
15.2
15.7
%
—
6
15
10
25
4.16
3.74
1.8
1.9
33.5
32.6
pg
—
10
25
33
166
2.18
3.71
7.0
3.3
1.7
2.2
mmol/l
0.38
26
130
57
354
1.85
3.56
3.4
3.1
2.5
2.5
mmol/l
0.66
50
306
78
534
1.75
3.51
4.7
4.0
22.7
9.0
mg/mmol
0.76
50
338
19
76
2.65
3.49
2.3
2.9
—
—
—
0
0
33
170
2.12
3.49
7.0
3.3
—
—
—
0
0
182
1599
2.34
3.48
35.4
16.1
27.9
24.7
mg/l
0.72
173
1309
56
349
1.83
3.45
7.7
4.6
—
—
—
0
0
29
143
2.20
3.42
5.1
2.8
4.4
4.2
kpa
0.29
29
136
29
144
2.18
3.36
5.1
3.8
1.1
0.9
%
0.17
15
47
32
167
2.09
3.27
7.2
3.4
5.8
5.8
kpa
0.01
32
160
7
11
6.54
3.21
10.0
15.9
—
—
—
0
0
7
11
6.54
3.21
2.3
1.1
—
—
—
0
0
12
39
3.21
3.14
2.8
2.9
0.8
1.1
nmol/l
—
7
31
48
293
1.84
3.13
1.5
1.4
2.5
2.7
g/l
0.28
35
179
10
29
3.58
3.09
1.1
1.4
—
—
—
0
0
26
130
2.15
2.97
5.5
3.9
0.1
0.2
%
0.27
11
39
20
91
2.33
2.84
2.0
2.4
—
—
—
0
0
27
140
2.07
2.81
5.9
3.8
—
—
—
0
0
10
31
3.34
2.81
4.6
3.1
65.4
58.9
%
—
10
31
61
413
1.68
2.76
6.4
3.6
88.9
88.1
%
0.08
61
406
26
134
2.08
2.75
5.4
3.9
0.2
0.2
%
0.00
12
42
7
14
5.14
2.75
3.0
3.4
—
—
—
0
0
59
397
1.69
2.73
2.0
1.8
463.6
454.3
pmol/l
0.09
43
330
55
365
1.70
2.68
6.7
4.1
—
—
—
0
0
86
645
1.58
2.55
2.7
2.2
—
—
—
0
0
8
21
3.92
2.49
1.3
1.5
—
—
—
0
0
8
21
3.92
2.49
1.3
1.5
—
—
—
0
0
8
21
3.92
2.49
1.3
1.5
—
—
—
0
0
8
21
3.92
2.49
1.3
1.5
—
—
—
0
0
6
12
5.12
2.42
1.2
1.3
—
—
—
0
0
181
1637
1.98
2.40
31.5
15.7
—
—
—
0
0
34
203
1.81
2.37
1.9
1.4
—
—
—
0
0
10
35
2.95
2.34
4.8
3.4
—
—
—
0
0
31
182
1.83
2.28
3.3
2.7
4.3
8.4
ug/l
0.94
26
153
7
18
3.99
2.27
1.3
1.2
—
—
—
0
0
7
18
3.99
2.27
1.7
1.3
—
—
—
0
0
32
191
1.80
2.23
3.4
2.4
7.5
8.2
umol/l
0.08
26
164
20
104
2.02
2.09
2.8
2.7
4.0
3.7
e9/l
0.26
13
77
17
83
2.14
2.08
7.6
4.0
—
—
—
0
0
7
20
3.59
2.07
2.0
1.1
—
—
—
0
0
14
63
2.31
2.06
1.1
1.5
—
—
—
0
0
6
15
4.09
2.05
3.3
1.8
—
—
—
0
0
6
15
4.09
2.05
1.2
1.4
—
—
—
0
0
34
214
1.71
1.99
6.4
5.7
0.3
1.4
mmol/l
0.95
25
175
18
92
2.05
1.97
5.2
2.5
1.1
1.3
%
0.40
18
92
24
139
1.82
1.85
2.9
3.8
—
—
—
0
0
5
12
4.24
1.83
3.6
2.3
450.6
499.7
min
—
5
7
181
1667
1.79
1.83
18.5
10.9
24.8
24.5
u/l
0.06
174
1595
25
149
1.77
1.77
9.9
3.8
—
—
—
0
0
22
126
1.84
1.76
5.8
3.6
0.7
0.5
%
—
9
32
8
30
2.73
1.74
5.4
3.0
4.5
4.8
e9/l
—
8
30
6
19
3.22
1.67
1.0
1.1
—
—
—
0
0
6
19
3.22
1.67
1.8
4.2
—
—
—
0
0
5
14
3.63
1.62
1.0
1.2
—
—
—
0
0
5
14
3.63
1.62
1.2
1.4
—
—
—
0
0
11
50
2.27
1.60
3.0
3.6
—
—
—
0
0
7
26
2.75
1.59
1.4
1.0
—
—
—
0
0
6
20
3.06
1.59
3.5
2.4
—
—
—
0
0
22
131
1.76
1.57
2.8
1.5
—
—
—
0
0
151
1350
1.46
1.56
31.2
17.1
38.8
39.4
%
0.50
79
886
10
44
2.34
1.56
1.0
1.1
—
—
—
0
0
8
33
2.48
1.55
2.9
2.2
—
—
—
0
0
162
1469
1.51
1.55
5.7
4.8
2.0
2.1
mu/l
0.23
150
1305
5
15
3.39
1.53
1.0
1.1
—
—
—
0
0
7
27
2.65
1.53
3.4
4.1
1.9
0.8
%
—
7
22
45
324
1.50
1.52
1.3
1.2
0.7
1.2
u/ml
1.34
11
98
109
1253
0.72
1.51
45.9
21.7
327.0
331.3
g/l
4.29
109
1242
135
1188
1.41
1.48
4.5
4.0
15.7
15.0
pmol/l
1.74
119
1043
5
16
3.18
1.44
1.2
1.3
—
—
—
0
0
14
74
1.96
1.43
4.5
2.5
—
—
—
0
0
164
1500
1.49
1.41
8.6
6.5
41.5
40.8
mmol/mol
0.40
149
1385
61
474
1.41
1.39
7.8
3.9
—
—
—
0
0
5
18
2.82
1.29
9.8
3.1
—
—
—
0
0
5
19
2.67
1.22
1.8
3.1
—
—
—
0
0
32
225
1.50
1.22
1.1
1.2
—
—
—
0
0
7
30
2.38
1.13
3.9
2.2
—
—
—
0
0
22
146
1.57
1.08
2.5
1.5
—
—
—
0
0
12
67
1.84
1.07
2.1
1.8
—
—
—
0
0
5
22
2.30
1.04
7.4
4.7
—
—
—
0
0
5
22
2.30
1.04
1.4
2.8
—
—
—
0
0
25
173
1.51
1.03
1.8
1.9
130.8
161.7
ug/g
0.28
19
138
14
85
1.69
0.97
11.4
7.6
23.0
24.8
mmol/l
2.05
14
75
6
27
2.26
0.94
2.3
1.3
—
—
—
0
0
8
42
1.94
0.89
2.9
2.4
7.3
7.9
kpa
—
8
36
6
30
2.03
0.87
1.3
1.2
14.8
16.0
u/l
—
6
24
13
82
1.63
0.80
11.2
7.0
—
—
—
0
0
14
94
1.53
0.69
1.1
1.3
—
—
—
0
0
166
1577
1.29
0.68
5.9
5.4
2.5
2.6
mmol/l
0.91
145
1416
162
1535
1.27
0.67
5.6
4.8
4.3
4.5
mmol/l
1.61
143
1390
5
28
1.80
0.66
1.6
1.3
—
—
—
0
0
13
89
1.49
0.59
1.7
1.4
—
—
—
0
0
18
132
1.40
0.59
1.5
1.3
—
—
—
0
0
71
626
1.21
0.59
7.3
5.4
3.4
2.9
ug/l
0.12
63
552
6
35
1.74
0.58
2.3
2.4
—
—
—
0
0
162
1545
1.24
0.56
6.2
5.0
6.1
6.1
mmol/l
0.09
143
1389
160
1524
1.24
0.56
5.7
4.7
1.4
1.5
mmol/l
0.89
142
1366
20
151
1.36
0.56
2.0
1.4
—
—
—
0
0
50
428
1.22
0.56
9.3
6.3
—
—
—
0
0
38
452
0.80
0.55
1.5
1.6
1.4
1.3
mmol/l
0.14
30
363
6
40
1.51
0.52
2.2
1.2
—
—
—
0
0
26
208
1.29
0.51
1.8
1.3
—
—
—
0
0
13
93
1.43
0.49
1.2
1.3
—
—
—
0
0
154
1470
1.20
0.48
5.2
4.2
1.4
1.3
mmol/l
0.57
135
1313
8
57
1.42
0.42
1.4
1.2
—
—
—
0
0
41
360
1.17
0.36
4.0
3.2
0.6
0.9
ug/l
1.44
29
245
6
44
1.37
0.34
2.5
2.0
—
—
—
0
0
8
66
1.22
0.27
4.5
5.5
—
—
—
0
0
39
350
1.14
0.27
9.2
5.0
1.0
1.0
kg/l
—
6
44
9
73
1.24
0.26
1.2
1.3
226.1
471.3
u/ml
—
9
67
6
81
0.73
0.24
1.0
1.3
—
—
—
0
0
46
499
0.90
0.22
4.2
3.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
11
89
1.25
0.21
1.1
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
5
43
1.17
0.21
1.2
1.1
—
—
—
0
0
44
406
1.11
0.20
1.3
1.3
—
—
—
0
0
113
1170
0.92
0.19
5.6
4.3
—
—
—
0
0
10
119
0.83
0.16
3.9
2.0
9.6
12.8
nmol/l
—
10
108
14
123
1.15
0.13
1.7
1.6
—
—
—
0
0
11
126
0.87
0.11
2.0
1.6
—
—
—
0
0
14
126
1.12
0.09
4.5
2.7
—
—
—
0
0
21
198
1.07
0.05
1.1
1.3
—
—
—
0
0
11
106
1.04
0.00
5.8
4.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
33.0
—
0
5
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
19.4
—
0
7

Mortality – FinRegistry

↥

Association

Association between endpoint CHRYSTAL_NOS and mortality.

Females

Parameter HR [95% CI] p-value
CHRYSTAL_NOS 1.612 [1.3, 2.0] < 0.001
Birth year 0.991 [0.98, 1.0] 0.049

During the follow-up period (1.1.1998 — 31.12.2019), 301 out of 641 females with CHRYSTAL_NOS died.

Males

Parameter HR [95% CI] p-value
CHRYSTAL_NOS 1.755 [1.31, 2.36] < 0.001
Birth year 0.982 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 218 out of 482 males with CHRYSTAL_NOS died.

Mortality risk

Mortality risk for people of age

years, who have CHRYSTAL_NOS.

N-year risk Females Males
1 0.143% 0.325%
5 0.84% 1.923%
10 2.169% 4.736%
15 4.007% 8.626%
20 7.146% 14.061%

Relationships between endpoints

↥

Index endpoint: CHRYSTAL_NOS – Other/unspecified crystal arthropathies

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data